Cargando…
Combating breast cancer progression through combination therapy with hypomethylating agent and glucocorticoid
Breast cancer is the leading cause of cancer-related death in women. Among breast cancer types, triple-negative breast cancer (TNBC) accounts for 15% of all breast cancers with aggressive tumor behavior. By using bioinformatic approaches, we observed that the microRNA-708 promoter is highly methylat...
Autores principales: | Chu, Yu-Hsin, Huang, Yi-Chen, Chiu, Pei-Yun, Kuo, Wen-Hung, Pan, Yan-Ru, Kuo, Yuan-Ting, Wang, Rong-Hsuan, Kao, Yu-Chin, Wang, Yi-Hsiang, Lin, Yi-Fan, Lin, Kai-Ti |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10148121/ https://www.ncbi.nlm.nih.gov/pubmed/37128608 http://dx.doi.org/10.1016/j.isci.2023.106597 |
Ejemplares similares
-
Identifying genetic hypomethylation and upregulation of toll-like receptors in Kawasaki disease
por: Huang, Ying-Hsien, et al.
Publicado: (2017) -
Aberrant DNA hypomethylation of miR-196b contributes to migration and invasion of oral cancer
por: HOU, YU-YI, et al.
Publicado: (2016) -
Optimization of the Field Plate Design of a 1200 V p-GaN Power High-Electron-Mobility Transistor
por: Liu, Chia-Hao, et al.
Publicado: (2022) -
Surfactin secreted by Bacillus amyloliquefaciens Ba01 is required to combat Streptomyces scabies causing potato common scab
por: Feng, Ru-Ying, et al.
Publicado: (2022) -
Dysregulation of cystathionine γ‐lyase promotes prostate cancer progression and metastasis
por: Wang, Yi‐Hsiang, et al.
Publicado: (2019)